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Introduction
!
The management of esophageal perforations and
postoperative leaks is still controversial. Prompt
endoscopic stenting and drainage of perivisceral
collections has been shown to be effective and
may improve survival [1]. Introduced for the pal-
liation of malignant dysphagia, self-expanding
metal stents (SEMSs) are increasingly usedworld-
wide in the management of leaks despite the lack
of Food and Drug Administration (FDA) approval
[2]. The incidence of stent migration is lower that
with self-expanding plastic stents (SEPSs) be-
cause of the proliferation of granulation tissue
and subsequent embedding of the uncovered por-
tion of the mesh, which acts as an anchor [3,4].
The amount of granulation tissue depends on a
combination of factors, such as type and size of
the stent, radial and axial force, and the duration
of stenting (>2 weeks). The removal of SEMSs is
challenging and frequently associated with bleed-
ing and mucosal tears [5]. Temporary placement
of a new stent within the first stent (stent-in-
stent technique) may facilitate mobilization and
safe removal of the embedded stent by inducing
pressure necrosis of the granulation tissue [6].
We report our experience with the stent-in-stent
procedure in patients previously treated for
esophageal postoperative leaks, perforations, and
malignant dysphagia and compare our results
with those in the current literature.
Patients and methods
!
Between July 2001 and August 2014at our insti-
tution, 238 partially or fully covered SEMSs were
placed for the palliation of malignant dysphagia
(n=198) and for the management of esophageal
perforations or postoperative leaks (n=40). The
stent-in-stent technique was used to remove an
embedded stent in four patients with previous
anastomotic leak or perforation and in one pa-
tient undergoing chemoradiotherapy for squa-
mous cell esophageal carcinoma. Patient data
were retrieved from the medical charts. The hos-
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Background: Endoscopic stenting is a widely used
method for managing esophageal anastomotic
leaks and perforations. Self-expanding metal
stents (SEMSs) have proved effective in sealing
these defects, with a lower rate of displacement
than that of self-expanding plastic stents (SEPSs)
as a result of tissue proliferation and granulation
tissue ingrowth at the uncovered portion of the
stent, which anchor the prosthesis to the esopha-
geal wall. Removal of a fully embedded stent is
challenging because of the risk of bleeding and
tears.
Materials and methods: Temporary placement of
a new stent within the first stent (stent-in-stent
technique) may facilitate the mobilization and
safe removal of both stents by inducing pressure
ischemia of the granulation tissue. We report our
own experiencewith the stent-in-stent technique
in five consecutive patients in whom a partially
covered Ultraflex stent had previously been im-
planted and compare our results with those in
the current literature.
Results: The first SEMSs remained in place for a
median of 40 days (range 18–68) without dis-
placement. Placement of the new stent was tech-
nically successful in all patients. All stents were
left in place for a median of 9 days. The overall
stent-in-stent success rate was 100% for the re-
moval of embedded stents. No serious adverse
events related to the procedure occurred.
Conclusion: The procedure was safe, well toler-
ated, and effective. The use of a partially covered
Ultraflex stent of the same size as the old stent
for a limited time (≤6 days) was consistently suc-
cessful.
pital internal review board approved the use of the stent-in-stent
technique. Informed consent was obtained for all endoscopic
procedure.
Before placement of the initial stent, upper gastrointestinal (GI)
endoscopy, a Gastrografin swallow study, and thoraco-abdomi-
nal computed tomography (CT) were routinely performed. Before
endoscopic intervention, patients with anastomotic leak or per-
foration underwent percutaneous drainage of perivisceral collec-
tions under ultrasound or CT guidance. Diagnostic upper GI en-
doscopes (EG29-i10; Pentax Medical, Tokyo, Japan) were used
for stent positioning and removal. All procedures were per-
formed in the operating room with the patients under general
anesthesia. The site of the lesionwasmarkedwith external radio-
paque markers, and the stents were deployed under fluoroscopic
guidance. In all patients, a partially covered, proximal release Ul-
traflex stent (Boston Scientific, Natick, Massachusetts, USA) was
implanted.
The technical success of the procedure was immediately evaluat-
ed with endoscopy (correct position of the stent without air leak)
and fluoroscopy. Chest radiography and a Gastrografin swallow
study on the following day were used to check the position of
the stent and sealing of the fistula; if no evidence of leakage was
found, patients were allowed to start a semi-liquid diet. After a
variable period of time, upper GI endoscopy for possible stent re-
moval was performed. When the stent was found to be embed-
ded and immediate removal was not considered possible, a new
partially or fully covered SEMSwas placed inside the lumen of the
first stent to induce pressure necrosis according to the stent-in-
stent technique.
All secondary procedures were performed in the operating room
with the patients under general anesthesia andwith fluoroscopic
assistance. The new deployed stent had a diameter that was at
least equal to that of the first embedded stent in order to provide
sufficient radial pressure. Care was taken to ensure that the new
stent completely overlapped the reactive tissue ingrowth inside
the lumen of the old partially covered stent (●" Fig.1). Ultraflex
and Wallflex SEMSs (Boston Scientific) were used for the stent-
in-stent technique. Removal of the stents was planned after at
least 6 days. During the removal procedure, both stents were
grasped at the proximal cup purse string with an endoscopic
snare or rat-toothed forceps. In only one case, the old stent had
to be grasped at the distal margin and inverted. No overtubes
were used during removal.
Results
!
Five patients (four men and one woman) with a median age of
59.6 years (range 32–86) were treated with six stent-in-stent
procedures. The indications for stent placement were esophago-
jejunal anastomotic leak following total gastrectomy (n=2), eso-
phago-gastric anastomotic leak following subtotal esophagect-
omy (n=1), iatrogenic esophageal perforation during pneumatic
dilation for caustic stricture (n=1), and palliation of dysphagia
due to squamous cell carcinoma of the upper thoracic esophagus
(n=1) (●" Table1). Placement of the first partially covered nitinol
stent was technically successful in all patients. The SEMSs re-
mained in place for a median of 40 days (range 18–68) without
displacement. The Gastrografin swallow study revealed no extra-
vasation of contrast, and all patients resumed a semi-liquid diet.
Follow-up endoscopy demonstrated complete embedding (>80%
of the circumference) of the proximal and distal cups of the stent
(●" Fig.2).
Placement of the new stent was technically successful in all pa-
tients (●" Table2). A partially covered stent (Ultraflex) was insert-
Fig.1 Stent-in-stent
technique to remove a
fully embedded esoph-
ageal metal stent. Care
is taken to ensure that
the new stent comple-
tely overlaps the reac-
tive tissue ingrowth
inside the lumen of the
old partially covered
stent. Lateral chest
radiograph shows
almost complete over-
lapping of two Ultraflex
esophageal stents after
a stent-in-stent proce-
dure. This results in op-
timal radiation pressure
over the inflammatory/
granulation tissue. The
red line corresponds to
the first stent, and the
green line to the new
stent.
Table 1 Indications for stent placement and outcome of the primary stent implant in five patients.
Patient Indication Distance from
incisors, cm
Size of lesion Stent (stent size) Time stent
in situ, d
Stent ingrowth, percen-
tage circular extension
1 Iatrogenic perforation 30 5mm Ultraflex 12 cm
(28–23mm)
64 100%
2 Anastomotic leak after total
gastrectomy
37 1/3 of circumference Ultraflex 10 cm
(23–18mm)
68 80%
3 Anastomotic leak after total
gastrectomy
38 1/3 of circumference Ultraflex 12 cm
(28–23mm)
18 80%
4 Anastomotic leak after subtotal
esophagectomy
30 10mm Ultraflex 12 cm
(28–23mm)
26 100%
5 Palliation of squamous cell
carcinoma
20 5 cm Ultraflex 12 cm
(23–18mm)
25 100%
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ed in four procedures, and a fully covered nitinol stent (Wallflex)
in two. All stents were left in place for a median of 9 days (range
6–17). In four patients, the stents were successfully removed at
the planned date (●" Fig.3). In the patient with esophageal tumor,
it was decided to remove the stent because of the onset of dys-
pnea related to extrinsic compression of the trachea and left
main bronchus. In one patient, complete embedding of the prox-
imal end of the first stent was seen after removal of the second
fully covered stent at 17 days after implant. Another partially
covered nitinol stent was then placed, and both stents were easi-
ly removed after 6 days. The procedural time for removal varied
between 20 and 30 minutes.
The overall stent-in-stent success rate for the removal of embed-
ded stents was 100%. No serious adverse events related to the
procedure occurred. In one patient, a reduced fistula size but per-
sistent anastomotic leakage was noted after stent removal, and
an Over-the-Scope Clip (OTSC; Ovesco Endoscopy AG, Tübingen,
Germany) was successfully deployed. One patient developed dys-
phagia 2 months after the stent-in-stent procedure, which re-
solved after Savary bougie dilation of an anastomotic stricture.
No further complications occurred during a minimum follow-up
time of 5 months.
Discussion
!
Over the past decade, stent placement has developed and
emerged as an effective and potentially life-saving treatment for
patients with esophageal perforations and postoperative leaks
[7]. Currently, most of the available data concern plastic stents
(SEPSs), which are the only FDA-approved removable stents [8].
However, stent migration due to a lack of proper anchorage to
the esophageal wall occurs in up to 88% of these patients and is
a source of major morbidity [9–11]. Fixing with endoclips has
been suggested, with controversial results [12]. Despite the lack
of FDA approval, SEMSs seem preferable to SEPSs because the
embedded uncovered mesh may serve as an anchor, ensuring
adequate sealing with lower displacement rates. The extent of
tissue granulation overgrowth varies among studies (0–47%)
[13]. No relationship has been found between the extent of the
tissue response and the specific type of SEMS or previous chemo-
therapy and/or radiotherapy. Stent material and radial force have
been suggested to have a role. It is well-known that the tissue re-
action increases with time, but strong stent embedding can al-
ready be seen as early as 10 to 15 days after placement. The tissue
response consists of well-vascularized granulation tissue, reac-
Fig.2 Endoscopic
view of complete em-
bedding of the proximal
cup of the Ultraflex
stent. The reactive
inflammatory tissue
completely overlaps
the uncovered proximal
portion of the mesh
(100% circumferential
ingrowth).
Table 2 Outcome of stent-in-stent procedure in five patients.
Patient Stent (stent size) Time to removal of
both stents, d
Removal procedure Outcome Follow-up, mo
1 Wallflex 15 cm
(25–18–23mm)
12 Uncomplicated No visible fistula 26
2 Wallflex 15 cm
(25–18–23mm)
17 Ultraflex still embedded at
the proximal cup (75% of
circumference)
Placement of Ultraflex 10 cm
(23–18mm); successful removal
after 6 days; no visible fistula
22
3 Ultraflex 12 cm
(28–23mm)
6 Uncomplicated No visible fistula 17
4 Ultraflex 12 cm
(28–23mm)
6 Uncomplicated Small residual fistula (2mm);
endoclip application
15
5 Ultraflex 12 cm
(23–18mm)
6 Uncomplicated Reduction of dyspnea 5
Fig.3 The proximal (a) and distal (b) cups of the old Ultraflex stent after the stent-in-stent procedure. There is no evidence of residual granulation tissue. The
rat-toothed forceps are useful to grasp the proximal retrieval string for removal (c).
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tive hyperplasia, and fibrotic tissue penetrating through the un-
coated mesh of the stent [5].
The removal of embedded stents is challenging and associated
with bleeding or mucosal tears. Argon plasma coagulation (APC)
has been found to be time-consuming, technically demanding,
and associated with significant complications [2,4]. Previous re-
ports have already shown that the radial force of a second stent
placed within the first stent results in pressure ischemia and ne-
crosis of granulation tissue, facilitating successful mobilization
with subsequent removal of both stents (stent-in-stent tech-
nique) [14,15].
Our results with the stent-in-stent technique are similar to those
reported in other series, in which, with one exception [15], plas-
tic stents have been used in the majority of patients (●" Table3).
However, we believe that using the same type of partially covered
metal stent, with a diameter and length identical to those of the
old one, optimizes the contact surface between the two prosthe-
ses and can maximize ischemic pressure. This strategy was suc-
cessful in four of our patients. In addition, the Ultraflex stents
caused negligible tissue overgrowth in their uncovered portion,
presumably because of the short implantation time (≤6 days).
Conclusion
!
We conclude that the stent-in-stent technique, despite the need
of an additional endoscopic procedure with the insertion of a
new stent and extra costs, is technically feasible, safe, and effec-
tive for the removal of partially covered stents that have become
partially or totally embedded in the esophageal wall.
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Table 3 Stent-in-stent procedure: literature overview.
First Author Year Patients,
n
Procedures,
n
Type of stent Indication for primary stent implant Complication
rate, %
Success
rate, %
Leak Perforation Benign
stricture
Malignant
stricture
Evrard [3] 2004 5 5 SEPS – 3 2 – 0 100
Tunçözgür [6] 2006 1 1 SEPS – – 1 – 0 100
Eisendrath [4] 2007 11 11 SEPS 11 – – – 0 100
Hirdes [14] 2011 19 23 12 BD, 9 SEPS,
2 SEMS (Niti-S)
7 8 1 3 Severe bleed-
ing (n =1)
91
Vasilikostas [15] 2014 5 5 SEMS (Wallflex) 4 – 1 – 0 100
Present series 5 6 SEMS (2 Wall-
flex, 4 Ultraflex)
3 1 – 1 0 100
Total 46 51
SEPS, self-expanding metal stent; BD, biodegradable stent; SEMS, self-expanding metal stent.
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